RSV is responsible for around 1 lakh deaths, over 3.6 million hospitalisations in children under age of 5 every year, ...

When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to ...

New prevention measures for RSV have led to a major drop in hospitalizations among infants, according to a new CDC study.

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

Experts say new immunisation program working, but some babies missing outThe number of Australian babies admitted to hospital ...

Adults hospitalized for RSV face higher odds of cardiac complications than those with COVID-19 or influenza, especially in ...

Discover a study that highlights the importance of identifying high-risk children through biomarkers and better understanding ...

Respiratory syncytial virus (RSV) causes millions of childhood illnesses yearly, particularly in poorer countries. On 30 May 2025, the World Health Organisation issued its first global guidance ...

June 2, 2025 - Last Friday, the World Health Organization (WHO) published its first-ever position paper on immunization ...

Universal immunisation with nirsevimab significantly reduces hospitalizations and paediatric intensive care admissions for ...